InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Gray Susannah, Director. Insider active across 2 companies, notably Maravai Lifesciences Holdings, INC.. Aggregated, 9 reports have been published. Activity tracked since 19 November 2021. The latest transaction was filed on 26 May 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Gray Susannah
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
6,009 sharesOrdinary SharesSEC:0001833453-26-000006:0
46,293 shares0Class A Common StockSEC:0001833453-26-000004:0
89,139 shares@ US$2.1644.7% of flowClass A Common StockSEC:0001823239-25-000088:0
10,649 shares0Ordinary SharesSEC:0001415889-25-014009:0
20,645 shares@ US$10.78100.0% of flowClass A Common StockSEC:0001823239-24-000072:0
10,537 shares0Ordinary SharesSEC:0001415889-24-012913:0
24,000 shares0Class A Common StockSEC:0001823239-23-000059:0
9,132 shares0Ordinary SharesSEC:0001415889-23-007376:0
4,271 shares0Class A Common StockSEC:0000899243-21-045773:0
9 of 9 declarations
About Gray Susannah
Susannah Gray is a Director and declarant for Maravai Lifesciences Holdings, INC. and Theravance Biopharma, Inc. The record shows 9 filings in total, with recent sampled filings dated from 2021-11-23 to 2026-06-16, a modal transaction nature of Attribution, and top_filings amounts ranging from EUR 205825.9937570995 on 2024-05-24 at Maravai Lifesciences Holdings, INC. to EUR 166682.0878603167 on 2025-06-18 at Maravai Lifesciences Holdings, INC., with an additional 2026-06-16 filing at Theravance Biopharma, Inc. with no amount stated.
